NASH Clinical

 

Julius Clinical’s proprietary global network dedicated to nonalcoholic steatohepatitis research.

NASH Clinical comprises a global network of clinicians, investigators, and experts in the NASH field. NASH Clinical’s mission is to help decrease the problems that arise from nonalcoholic steatohepatitis (NASH) worldwide.

 

Who we are

The participating clinicians in NASH Clinical are endocrinologists, gastroenterologists, diabetologists, and general internists. They have connections with numerous hospitals worldwide. NASH Clinical’s goals are to raise awareness and share insights about this endemic disease, collaboratively create easy and accurate diagnostic tools that can be used to identify patients, and to conduct fatty liver clinical trials that could help mitigate the risks associated with this disease.

Read more

Where we come from

NASH Clinical was created by Julius Clinical in 2018. The founding members are academic researchers who were — and continue to be — connected through research, education, or other activities in this area.

With the deep experience of NASH Clinical’s sites and investigators, and the cohesion derived from lengthy relationships and fast, transparent communication, we have the tools in place to precisely determine the potential of your novel NASH treatment.

Get more info

What we do

Interdisciplinary collaboration is essential to combat NASH. The aim of this network is to work collaboratively, discover and disseminate insights, create advanced diagnostic tools, and conduct groundbreaking NASH clinical trials.

Recruitment in NASH is an especially difficult hurdle, with screening failure rates that often exceed 95%. NASH Clinical’s scientific approach and wealth of experience have helped refine our recruitment procedures to speed study startup and project timelines.

Who we are

The participating clinicians in NASH Clinical are endocrinologists, gastroenterologists, diabetologists, and general internists. They have connections with numerous hospitals worldwide. NASH Clinical’s goals are to raise awareness and share insights about this endemic disease, collaboratively create easy and accurate diagnostic tools that can be used to identify patients, and to conduct fatty liver clinical trials that could help mitigate the risks associated with this disease.

Read more

Where we come from

NASH Clinical was created by Julius Clinical in 2018. The founding members are academic researchers who were — and continue to be — connected through research, education, or other activities in this area.

With the deep experience of NASH Clinical’s sites and investigators, and the cohesion derived from lengthy relationships and fast, transparent communication, we have the tools in place to precisely determine the potential of your novel NASH treatment.

Get more info

What we do

Interdisciplinary collaboration is essential to combat NASH. The aim of this network is to work collaboratively, discover and disseminate insights, create advanced diagnostic tools, and conduct groundbreaking NASH clinical trials.

Recruitment in NASH is an especially difficult hurdle, with screening failure rates that often exceed 95%. NASH Clinical’s scientific approach and wealth of experience have helped refine our recruitment procedures to speed study startup and project timelines.

NASH Clinical team

We believe that a multidisciplinary network approach is needed to optimise NASH clinical studies and collect meaningful data. Our team of experts are highly skilled in areas that position them to provide key perspectives on NASH research.

Martin czakon
Elizabeth liano callahan
Manuel castro cabezas
Vivian de jong

Related webinars

NAFLD: patient identification strategies

In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

Public health and policy responses to NAFLD/NASH

Topics that has been discussed: The Impact of NAFLD/NASH What is being done to tackle NAFLD/NASH globally and nationally What still needs to be done in the fight against NAFLD/NASH How can you/your country advance the battle against ...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

NASH resources

Explore our NASH capabilities, case studies, and other resources.

Download

"*" indicates required fields

*

Request for proposal

"*" indicates required fields

*
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn